Results from NIH-funded animal models will inform the development of vaccines for humans. Using advanced immunological ...

Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals' immune ...

Scientists have taken a big step toward making an effective HIV vaccine. An HIV vaccine is one step closer to reality ...

Neoadjuvant pembrolizumab (Keytruda) plus chemotherapy followed by adjuvant pembrolizumab led to significant improvement in ...

Researchers at the Duke Human Vaccine Institute undergo the first ever breakthrough in developing a broadly neutralising ...

Uganda Aids Commission says more than 50,000 Ugandans contract HIV every year, with around 17,000 HIV-related deaths among ...

A trial on humans for HIV vaccine shows it triggers neutralizing antibodies in the body leading to a promising future for a ...

Using a combination of cutting-edge immunologic technologies, researchers have successfully stimulated animals’ immune ...

A new HIV vaccine candidate developed by the Duke Human Vaccine Institute showed promise in a phase 1 trial, generating ...

The findings, published today in Nature Immunology, are an encouraging, incremental step in developing a preventive HIV ...

An HIV vaccine is one step closer to reality following a human trial that produced rare and elusive antibodies, a new study ...

Novel Vaccine Concept Generates Immune Responses that NIH Says Could Produce Multiple Types of HIV Broadly Neutralizing ...